Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Recruiting now · Phase 4

Conditions studied: Back Pain, Chronic Pain

In brief

Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.

Key facts

Study ID: NCT06395428
Run by: Western Michigan University School of Medicine
People needed: 75
Starts: 2024-07-09
Expected to finish: 2027-04-15
Last updated by the study team: 2024-07-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Age 18 - 65 years old
Presenting to the Bronson ED with a chief complaint of acute, non-traumatic back pain
VAS score >5 cm

You may not qualify if…

Back pain due to traumatic injury
Experiencing saddle anesthesia
Has bowel or bladder dysfunction
Has an abnormal neurological exam
Requires imaging in ED
Has a Glascow coma score <15
Has one or more abnormal vital signs:
HR>120, SBP>180 or <90, temperature >38°, O2 saturation<92%
Has an allergy to ketorolac or haloperidol
Has a known diagnosis of Lewy Body Dementia
Has a known diagnosis of glaucoma.
Is known to be pregnant or breastfeeding
Is a prisoner or ward of the state
Is unable to consent for themselves/ non-english speaking
In the opinion of the attending physician or investigator the patient should not participate in the research

Where it is running

Bronson Methodist Hospital — Kalamazoo, Michigan, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.